ORG Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$37.9K Buy
108
+59
+120% +$19.9K 0.01% 638
2025
Q3
$15.8K Sell
49
-6
-11% -$1.87K ﹤0.01% 857
2025
Q2
$21.8K Buy
+55
New +$22.1K ﹤0.01% 732
2025
Q1
Sell
-82
Closed -$30.2K 1461
2024
Q4
$30.2K Sell
82
-37
-31% -$15.5K ﹤0.01% 654
2024
Q3
$61.9K Hold
119
0.01% 474
2024
Q2
$63.6K Buy
119
+103
+644% +$54.4K 0.01% 734
2024
Q1
$8.26K Sell
16
-69
-81% -$34.3K 0.02% 303
2023
Q4
$40.1K Buy
+85
New +$39.3K 0.01% 570

Other funds holding ELV

ORG Partners's ELV Position: Q4 2025 in Review

ORG Partners increased its Elevance Health (ELV) stake by 120% in Q4 2025, buying an estimated $19.9K and bringing the position to 108 shares worth $37.9K. The position accounts for 0.01% of the portfolio, ranked #638.

ORG Partners first reported a position in ELV in Q4 2023 and has held it in 8 quarters since. The position peaked at $63.6K in Q2 2024. 1,553 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • ORG Partners held 108 shares of Elevance Health worth $37.9K as of Q4 2025.
  • ORG Partners bought 59 Elevance Health shares in Q4 2025, an estimated $19.9K.
  • Elevance Health made up 0.01% of ORG Partners's portfolio in Q4 2025, its #638 holding.
  • ORG Partners first reported a position in Elevance Health in Q4 2023 and has held it in 8 quarters since.
  • ORG Partners's Elevance Health position peaked at $63.6K in Q2 2024.
  • 1,553 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.